C. difficile Testing in the Time of COVID-19, a 30-minute Discussion

Dr. David Lyerly, Chief Scientific Officer at TECHLAB, led a 30 minute discussion during which he reviewed the relationship between C. difficile, acute respiratory disease, and hospital acquired infections. We also discussed the latest IDSA guidelines, as well as practical C. difficile testing solutions to help laboratories adapt to changing demands due to COVID-19. A recording of the webinar can be found here.

April 21, 2020 News

TECHLAB®, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics in the areas of intestinal inflammation, antibiotic associated diarrhea and parasitology.